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Abstract: Glucose phosphorylating enzymes are crucial in the regulation of basic cellular processes,
including metabolism and gene expression. Glucokinases and hexokinases provide a pool of
phosphorylated glucose in an adenosine diphosphate (ADP)- and ATP-dependent manner to shape
the cell metabolism. The glucose processing enzymes from Kluyveromyces lactis are poorly characterized
despite the emerging contribution of this yeast strain to industrial and laboratory scale biotechnology.
The first reports on K. lactis glucokinase (KlGlk1) positioned the enzyme as an essential component
required for glucose signaling. Nevertheless, no biochemical and structural information was
available until now. Here, we present the first crystal structure of KlGlk1 together with biochemical
characterization, including substrate specificity and enzyme kinetics. Additionally, comparative
analysis of the presented structure and the prior structures of lactis hexokinase (KlHxk1) demonstrates
the potential transitions between open and closed enzyme conformations upon ligand binding.
Keywords: Kluyveromyces lactis; glucokinase; sugar metabolism
1. Introduction
Glucose is one of the main factors in metabolism and key regulators of gene expression in
eukaryotic organisms, including yeast, protists, plants, and mammals. Glucose-dependent regulation
requires glucose phosphorylation provided by glucose-phosphorylating enzymes, glucokinases, and
hexokinases. These enzymes are responsible for intracellular trapping and metabolism initiation of
monosaccharides and catalyze ATP-driven phosphorylation, yielding ADP and glucose-6-phosphate.
Glucose phosphorylation is also considered as drug target against parasitic protists [1–3]. Additionally,
some ADP-dependent sugar kinases were also characterized, but their role remains more elusive [4–6].
In yeast, plant and mammalian cells’ sugar kinases were shown to be responsible for glucose
sensing and signaling [7–10], positioning those enzymes as providers of a carbon source and regulators
of sugar-dependent cellular mechanisms. A number of hexokinases were demonstrated to translocate
to the nucleus and intercede in the process of glucose repression of transcription in yeast [11] and
plants [12]. In mammals, hexokinases have been shown to play a role in the mechanisms of sugar
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homeostasis [13]. Although the hexokinase interacting partners were shown to play a critical role
in the activity of those enzymes [11,12,14,15], the limited structural information and lack of in vivo
studies hinder the complete understanding of hexokinase role in nutrient signaling [16–18].
Kluyveromyces lactis is an emerging tool in biotechnology. Since the early 1990s, it has been
employed as a host for recombinant protein expression for industrial use (summarized in [19]). One of
the most important examples relates to its use in industrial production of lactase and bovine chymosin,
enzymes which are important in food biotechnology [20]. Due to the growing importance of K. lactis
in biotechnology, research on biology and metabolism of this microorganism gains value for both
scientific and industrial reasons.
KlGlk1 was reported for the first time by Kettner and colleagues [21]. The group identified the
KLLA0C01155g gene in K. lactis genome on the basis of its high similarity to Saccharomyces cerevisiae
glucokinase (ScGlk1, nucleotide identity 62.4%) and glucokinase-like protein ScEMI2 (nucleotide
identity 63.3%) genes. Genomic analysis, followed by isolation and functional analysis of the protein,
revealed its enzymatic activity and specificity. The KlGlk1 mutants denoted the role of the enzyme as an
accessory glucose phosphorylating protein (to KlHxk1) which might act as a glucose phosphorylation
enzyme with currently unknown physiological function.
So far, KlHxk1 hexokinase is the only structurally characterized sugar metabolizing enzyme from
K. lactis [22–24]. Here, we extend the structural understanding of K. lactis glucose phosphorylating
enzymes. We have expressed and purified recombinant KlGlk1 and solved its crystal structure
at 2.6 Angstrom (Å) resolution. Comparative analysis of the structure of KlGlk1 reported in this
study and the prior structure of KlHxk1 demonstrates the transitions between open and closed
enzyme conformations.
2. Results and Discussion
2.1. Biochemical Characterization
We have recombinantly expressed, purified, and crystalized KlGlk1 glucokinase from K. lactis
and characterized its enzymatic properties. First, we analyzed the protein’s thermal stability using
both thermal shift assay (TSA) and Tycho analysis (Figure S1). Using these methods, the unfolding
temperatures were determined at 41.9 ± 0.1 ◦C and 53.6 ± 0.05 ◦C for TSA and Tycho, respectively.
Values obtained by TSA and Tycho cannot be directly compared due to different temperature gradients
and readout methodology used by both techniques, although both document relatively low thermal
stability of the protein.
Next, we assayed the protein activity using constant ATP concentration equal to 0.5 mM and
the standard Michaelis–Menten model to quantify the affinity (Km) for glucose (Figure 1A). Tested
conditions yielded the apparent kinetic parameters kcat (app) = 150 s−1 and Km (app) = 0.08 mM.
In the previous work, Kuettner and colleagues observed that K. lactis JA6∆rag5 strain lacking
KlHxk1 hexokinase revealed significant growth on glucose, but not on fructose. Thus, we tested
KlGlk1’s ability to catalyze phosphate transfer from ATP to fructose, and we observed no such activity
at tested conditions.
Sugar kinases often exhibit inhibition by ATP. The phenomenon of substrate inhibition has been
described for hexokinases which may be inhibited even by physiological concentrations of ATP [25].
Hence, we tested if KlGlk1 is prone to substrate inhibition by ATP at a concentration above 0.25 mM
(Figure 1B). We used fixed glucose concentration (0.5 mM) to determine the apparent kinetic parameters
(kcat (app) = 400 s−1, Km (app) = 0.15 mM) of KlGlk1 for ATP concentrations preceding substrate inhibition
range. Comparative fitting of a standard Michaelis–Menten model with and without Hill coefficient
(Figure S2A,B) revealed strong positive cooperativity at low ATP concentrations as indicated by the
Hill coefficient of 1.97 determined from the V = Vmax*[ATP]h/(Kmh + [ATP]h) equation. Sigmoidal
shape of the Hill plot (Figure S2C) suggests that KlGlk1 exists in two states with different catalytic
activity, with an apparent transition point at 45 µM ATP. At higher ATP concentrations, abnormally
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strong substrate inhibition takes place, which in pair with positive cooperativity observed in case of
KlGlk1 could be explained, among others, by protein dimerization. To fit the theoretical model to our
data, we combined the classical Yoshino and Murakami substrate inhibition model of a complete type,
which was previously validated on Escherichia coli phosphofructokinase II, with a kinetic model derived
for dimerizing enzymes [26,27]. Interestingly, numerical values of kcat and Km calculated based on
this model do not differ significantly from values estimated by classical Michaelis–Menten kinetics
for a lower concentration range. The ratio of a substrate inhibition constant to a Michaelis–Menten
constant (Ksi/Km) is close to 1.0, indicating a substrate inhibition of a complete type, which means
that at high substrate concentrations, the [ES1S2]2 complex is formed, and it is unable to perform the
reaction. As stated previously, strong substrate inhibition of KlGlk1 may be explained, among others,
by protein dimerization. Therefore, we investigated the possible dimerization using size-exclusion
chromatography coupled to light scattering (right-angle light scattering/low-angle light scattering
(RALS/LALS)). Analysis of RALS/LALS distribution demonstrated that KlGlk1 elutes as a dimer of
apparent molecular weight of 100 kDa (Figure S3). This observation goes in line with size-exclusion
chromatography retention time calibrated with molecular weight standards.
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model, R2 = 0.98; Vmax (0.085 ± 0.004 μM/s; dotted line), kcat (app) (150 s−1) Km (0.082 ± 0.013 mM). Error 
bars correspond to SD, N = 3. (b) Reaction velocity as a function of ATP concentration measured at 
0.5 mM glucose. Substrate inhibition is clearly visible starting from 0.25 mM ATP. Solid line indicates 
a substrate inhibition model with a correction for dimerization, R2 = 0.97. Error bars correspond to 
SD, N = 3. 
2.2. Overall Structure 
We crystallized KlGlk1 in an apo form. The crystal structure of KlGlk1 was determined by 
molecular replacement pipeline MoRda using Protein Data Bank (PDB) entry 3O8M as a search model 
[28]. The structure was refined to Rwork/Rfree values of 0.205/0.244 at 2.6 Å  resolution (Table 1). The 
asymmetric unit contains three KlGlk1 molecules and the unit cell belongs to C 2 2 21 space group 
(Figure 2a). 
KlGlk1 consists of two ribonuclease H-like type domains (Figure 2b, S4, and S5). The N-terminal, 
smaller domain K represents compact fold with beta strands in the domain’s core and short alpha 
helices located between strands 1–3 and 10–13 as well as at the top of domain K (helices 3 and 4). 
Larger domain Z consists of central mixed β-sheet (strands 10–13) flanked by alpha helices connected 
by the extended loops resulting in the elongated shape of the domain. Inspection of the overlap 
among the molecules contained in the asymmetric unit (ASU) does not indicate any significant 
structural differences as confirmed by low root mean square deviation (RMSD) values calculated by 
TM-align (RMSD calculated based on backbone C alpha atoms; RMSD values of backbone atoms of 
chains A/B, B/C and A/C are 0.53 for 469 residues, 0.62 for 469 residues, 0.54 for 470 residues, 
respectively) [29]. Two out of three KlGlk1 monomers (chains B and C) create relatively large contacts 
Figure 1. Kinetic analysis of KlGlk1 activity. (a) Reaction velocity as a function of glucose concentration
measured at 0.5 mM ATP. Solid line represents fit of standard Michaelis–Menten model, R2 = 0.98; Vmax
(0.085 ± 0.004 µM/s; dotted line), kcat (app) (150 s−1) Km (0.082 ± 0.013 mM). Error bars correspond to SD,
N = 3. (b) Reaction velocity as a function of ATP concentration measured at 0.5 mM glucose. Substrate
inhibition is clearly visible starting from 0.25 mM ATP. Solid line indicates a substrate inhibition model
with a correction for dimerization, R2 = 0.97. Error bars correspond to SD, N = 3.
2.2. Overall Structure
We crystallized KlGlk1 in an apo form. The crystal structure of KlGlk1 was determined by
molecular replacement pipeline MoRda using Protein Data Bank (PDB) entry 3O8M as a search
model [28]. The structure was refined to Rwork/Rfree values of 0.205/0.244 at 2.6 Å resolution (Table 1).
The asymmetric unit contains three KlGlk1 molecules and he u it cell belongs to C 2 2 21 pace group
(Figure 2a).
KlGlk1 co sists of two ribonuclease H-lik type doma ns (Figure 2b, Figures S4 and S5).
The N-terminal, smaller domain K represents compact fold with beta strands in the domain’s
core and short alpha helices located between strands 1–3 and 10–13 as well as at the top of domain K
(helices 3 and 4). Larger domain Z consists of central mixed β- hee (strands 10–13) fla ked by alpha
helices connected by the exte ed loops resulting in the elongat d shape of the domain. Inspection
of the overlap among the mol cules contained in the symmetric unit (ASU) does not indicate any
significant structural differences as confirmed by low root mean square deviation (RMSD) values
c lculated by TM-align (RMSD calculated b ed on backbone C alpha atoms; RMSD values of backbone
atoms of chains A/B, B/C and A/C are 0.53 fo 469 residues, 0.62 for 469 residues, 0.54 for 470 residues,
respectively) [29]. Two out of thre KlGlk1 monomers (c ins B and C) create relatively large contacts
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in the crystal, resulting in a total buried area of 372.6 Å2 (interaction surfaces were calculated using the
PISA server) [30]. The third molecule (chain A) creates less significant contacts only with monomer B,
resulting in a total buried area of 87.1 Å2. Nonetheless, this analysis of the arrangement of molecules
in the crystal does not indicate stable dimerization—the buried surface areas are too small to ensure
stable dimerization in solution. This is confirmed by automated analysis criteria implemented in the
PISA server, suggesting no formation of stable quaternary structures, thereby indicating protein’s
monomeric state in the presented crystal structure [30].
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2.3. Struct ral Comparison betw en KlGlk1 and KlHxk1 Glucokinases
KlHxk1, the closest homolog of KlGlk1, was crystallized in sev ral diff rent crystal forms showing
the m nomeric and di i states of the enzyme [23,24]. The structures of dimeric KlHxk1 show that
protein forms a symmet ical, ring-shaped homodimer with a head-to-tail arrangement of the protei
molecules. The struct res of apo and substr te (glucose) bound form provided molecular insight into
the mechanism of substr te binding and r late conformational hanges.
Comparative analysis of the KlGlk1 struct re and availab e KlHxk1 Protein Data B nk (PDB)
entries presenting the later protein in open state shows sign ficant similar ties n the overall struct re
despite low amino acid sequence ident ty (Figure S6). Superposition of KlGlk1 and KlHxk1 in open state
(PDB 3O08) demonstrat almost identical fol and position of both d mains. Only s ll differences
are noticeabl in the loop regio s b tween residues 135–145, 330–347, and 12–422, most probably due
to the flexible nature of these parts characterized by high B factors (Figure S7). More pronounced
differences ar vis ble i the 246–266 region, where KlHxk1 folds into a helix flanked by unstructur
regio compared to the long, unstructur d loop i the KlHxk1, as well as between 450–462 residues of
KlGlk1 where the loop region with an inserted shor helix i significan ly shorter i KlGlk1 than in
KlHxk1 (KlGlk1 residues 450–462 corresponds to residues 437–453 f KlHxk1).
The crystal structu es of KlHxk1 reported previously indicate that hexokinase undergoe profound
conformational changes upon substrate binding [23]. Superposition of the st ucture of KlGlk1 reported
in this study and the structure of KlHxk1 in a closed, substrate boun confo mati n (PDB 3O8M;
Figure 3) suggests that KlGlk1 structure has been determined in its open state (accordingly, no substrate
is present at the active site). Superpo ition and detail d comparison shows that the relative arr ngement
of sm ll and large domai s in KlGlk1 and substrate bound KlHxk1 is differe t. In KlHxk1, the substrate
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binding promotes the closed conformation of protein, whereas apo KlGlk1 remains in open state.
This phenomenon is typical for sugar phosphorylating proteins and has been described before [5,31].
The difference in protein conformation and domain location supports our suggestion concerning
KlGlk1 open state. Moreover, the protein part undergoing conformational change encompasses the
region of 115–195 residues that folds into helices H3 and H4 and stands S4–S7 with a 165–174 loop that
might be responsible for stabilizing the substrate at the active site of the enzyme.
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Figure 3. Comparison of crystal structures of KlGlk1 and KlHxk1 kinases. (a) Superposition of KlGlk1
and KlHxk1 (PDB:3o08) in open states. (b) Superposition of KlGlk1 in the open state and KlHxk1 in the
closed state (PDB:3o8m). (c) Superposition of active site residues of KlGlk1 and KlHxk1 in open state
(PDB:3o08). (d) Superposition of active site residues of KlGlk1 and KlHxk1 in closed state (PDB:3o8m).
Superpositions were made over large domains of KlGlk1 and KlHxk1 (TM-align module in PyMol
software, residues 2–60 and 220–481 for KlGlk1, residues 15–60 and 220–484 for KlHxk1).
We report here a KlGlk1 cry tal structure in an pen conformation. The kinetic assays performed
on recombinant protein confirmed protein activity towards glucose and no activity towards fructose.
We also observed a relatively strong substrate inhibition by ATP in the concentration range exceeding
0.25 mM. This indicates a tight regulation of KlGlk1 by ATP. The protein remains inactive when the
ATP level in the cell is high, which suggests that KlGlk1 serves as a safety mechanism preventing too
fast energy production. Both kinetic analysis and light scattering studies show that KlGlk1 forms a
dimer in solution, which is likely related to activity regulation by ATP.
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3. Materials and Methods
3.1. Cloning, Expression and Purification
The Kluyveromyces lactis KLLA0C01155g gene was codon optimized for improved expression in
Escherichia coli. The gene was synthesized (GenScript, Leiden, Netherlands) and subcloned to a pET24d
expression vector. N-terminal His-tagged KlGlk1 was expressed in E. coli BL21 (DE3) using terrific
broth medium supplemented with kanamycin. Briefly, cells were cultivated until OD600 value of 1 at
37 ◦C, the expression was induced with 0.5 mM isopropyl-β-d-thiogalactoside (IPTG), and cultures
were incubated for 16 h at 16 ◦C. After expression, cells were collected and resuspended in lysis buffer
containing 150 mM NaCl, 20 mM imidazole, 20 mM (4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid) (HEPES) pH 8.0 and lysed by sonication. Soluble fraction was loaded onto Ni-Sepharose (GE
Healthcare, Uppsala, Sweden) column equilibrated with lysis buffer. Protein was eluted with lysis buffer
containing 500 mM imidazole and mixed with Tobacco etch virus (TEV) protease. After incubation,
solution was loaded onto Ni-Sepharose resin to remove His-tag and TEV protease. Finally, KlGlk1
was concentrated and purified to homogeneity by gel filtration using Superdex 75 (GE Healthcare,
Uppsala, Sweden) in 150 mM NaCl, 20 mM HEPES, pH 8.0 (Figure S8). Fractions containing protein of
interest were pooled and concentrated to 10 mg/mL.
3.2. Crystallization and Structure Determination
Crystallization screening was carried out using commercially available buffer sets (Molecular
Dimensions) in a sitting-drop vapor diffusion setup by mixing 1 µL of protein solution and 1 µL
of buffer solution at room temperature. Diffraction quality crystals were obtained from condition
containing 0.15 M potassium bromide and 30% (w/v) poly(ethylene glycol) (PEG) monomethyl ether
(MME) 2000. Crystals were cryoprotected with 30% ethylene glycol in mother liquor and flash frozen
in liquid nitrogen.
Diffraction data were collected at 14.1 beamline at BESSY II, Berlin, Germany [32] using Pilatus 6M
detector to 2.6 Å resolution (Table 1). The data were indexed and integrated using XDS [33] then scaled
and merged using Scala [34]. Structure was solved using MoRda server [28] and Phaser [35] using PDB
3O8M as a search model. As the search model shared only 38% of its amino acid sequence identity with
KlGlk1, several parts of the model were manually rebuilt using Coot [36]. Restrained refinement was
performed using Phenix [37]. Five percent of the reflections were used for cross-validation analysis,
and the behavior of the Rfree was employed to monitor the refinement strategy. Water molecules were
added using Coot and subsequently manually inspected. The loop containing residues 43–48 (chain A;
43–49 for chain B) was not fully resolved in the electron density map and therefore was not modeled.
The final model comprises residues 2–481 from each monomer and 196 water molecules.
Table 1. Data collection and refinement statistics.
KlGlk1 (PDB 6R2N)
Data Collection
Space group C 2 2 21
Total reflections/Unique reflections 139134 (13371)
Cell dimensions 102.0 Å, 122.7 Å, 360.3 Å
900, 900, 900
Wavelength (Å) 0.9184
Resolution (Å) 49.08-2.596 (2.689-2.596)
Mean I/sigma (I) 13.6 (1.7)
Completeness (%) 99.58 (97.10)
Multiplicity 2.0 (2.0)
CC1/2 98.6 (52.8)
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Table 1. Cont.
KlGlk1 (PDB 6R2N)
Refinement
Reflections used in refinement 69952 (6762)
Reflections used for R-free 1099 (107)
R-work 0.2045 (0.3300)
R-free 0.2396 (0.3345)
Number of Atoms/Molecules
non-hydrogen atoms 11273
macromolecules 11032
ligands 45
solvent 196
B-factors
average B-factor (Å) 76.69
macromolecules (Å) 77.06
ligands (Å) 86.48
solvent (Å) 53.66
wilson B-factor (Å) 53.71
Ramachandran plot
Ramachandran favored (%) 96.88
Ramachandran allowed (%) 3.05
Ramachandran outliers (%) 0.07
R. m. s. deviations
Bonds (Å) 0.004
Angles (◦) 0.96
Rotamer outliers (%) 0.92
Clashscore 3.08
Values in parentheses are for high resolution shell.  Ligands in the presented structure include chemicals from
crystallization condition and cryoprotectant solution and are not biologically relevant in the presented context.
3.3. Activity Assay
KlGlk1 activity was assessed by monitoring the level of one of the reaction products
(glucose-6-phosphate) in a coupled glucose-6-phosphate dehydrogenase (G6PD) reaction essentially as
described previously [5,6]. Unless stated otherwise, the assays were performed at 37 ◦C in reaction
buffer (20 mM Tris-HCl pH 7.4, 250 mM sucrose, 50 mM KCl, 5 mM MgCl2) supplemented with
glucose-6-phosphate dehydrogenase (1 unit) and nicotinamide adenine dinucleotide phosphate (NADP)
(0.5 mM). The KlGlk1 protein concentration was adjusted to 0.16 mg/mL (3 µM).
3.4. RALS/LALS Analysis
The oligomeric state of KlGlk1 was investigated by size-exclusion chromatography (Superdex 200
Increase 10/300 GL column) coupled to right-angle light scattering (RALS) followed by measurement
of refractive index (RI) using OMNISEC REVEAL. Measurements were performed in 50 mM Tris pH
7.8, 200 mM NaCl, 5 mM β-ME buffer, and results were analyzed using OMNISEC software.
3.5. Protein Stability Analysis
Melting points (Tm-values) of KlGlk1 glucokinase were obtained using thermal shift assay (TSA)
and real time monitoring of changes in the intrinsic protein fluorescence by Tycho NT.6 [38]. For TSA
analysis, KlGlk1 (1 mg/mL) was incubated with Sypro Orange dye in 150 mM NaCl, 20 mM HEPES,
pH 8.0. Fluorescence signal of Sypro Orange was determined as a function of temperature between 5
and 95 ◦C in increments of 1.2 ◦C/min. The melting temperature was calculated as the inflexion point
of the fluorescence vs. temperature function. Each experiment was carried out in triplicate. For Tycho
NT.6 analysis, capillary was loaded with 10 µL of KlGlk1 (1 mg/mL) in 150 mM NaCl, 20 mM HEPES,
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pH 8.0 and heated from 35 to 95 ◦C in 3 min overall time. The melting temperature was calculated as
the inflexion point of the 350 nm/330 nm intrinsic fluorescence vs. temperature function.
3.6. Protein Data Bank Accession Code
Coordinates and structure factors for the KlGlk1 have been deposited in Protein Data Bank (PDB)
with code 6R2N.
4. Conclusions
Our study expands the understanding of glucose metabolizing enzymes in K. lactis by presenting
the first crystal structure of its unique glucokinase. The KlGlk1 structure along with the biochemical
data help to understand the mechanisms responsible for glucose sensing and signaling, therefore
allowing for more intensive use of K. lactis for both scientific and industrial applications.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/20/19/
4821/s1.
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ATP Adenosine triphosphate
ADP Adenosine diphosphate
Å Angstrom
TSA Thermal Shift Assay
RMSD Root Mean Square Deviation
IPTG Isopropyl-β-D-thiogalactoside
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid)
PEG Poly(ethylene glycol)
RALS/LALS Right-angle light scattering/low-angle light scattering
TRIS Trisaminomethane
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